Accretion Pharmaceuticals IPO GMP: Day 1 IPO Live Updates

Accretion Pharmaceuticals IPO GMP is ₹8 as of 14th May 2025. The IPO opens for bidding today, 14th May 2025, and will close on 16th May 2025. It is a bookbuilding IPO consisting of a fresh issue of 29.46 lakh shares worth ₹29.75 crores. The issue will be listed on NSE and SME on its tentative listing date, 21st May 2025. The price band for the Accretion Pharmaceuticals IPO is set between ₹96 and ₹101 per share. Retail investors can bid for a minimum lot of 1,200 shares worth ₹1,21,200. 

Accretion Pharmaceuticals IPO GMP Grey Market Premium

As of 14th May 2025, Accretion Pharmaceuticals IPO GMP stands at ₹0 per share. Thus, the estimated listing price would be ₹109 (101+8). This indicates that the estimated listing gain in this IPO could be 7.92%. However, GMP details are subject to change based on market conditions and fluctuations. Explore the table below to learn about recent Accretion Pharmaceuticals IPO GMP updates.

Accretion Pharmaceuticals IPO Details

Explanation

Accretion Pharmaceuticals IPO: Accretion Pharmaceuticals Limited has declared a price band of ₹96 to ₹101 per share. With this IPO, the company allows retail investors to bid for at least one lot of 1,200 shares worth ₹1,21,200. The face value of Accretion Pharmaceuticals Ltd.’s share is ₹10 per share. The shares of Accretion Pharmaceuticals Limited, one of the pharma companies in India, will be listed on NSE & SME on its tentative listing day, 21st May 2025. Scroll down to check GMP updates and Accretion Pharmaceuticals IPO reviews. 

Objectives of Accretion Pharmaceuticals IPO

Accretion Pharmaceuticals Limited proposed to utilise the proceeds from the book-building issue in the following objectives. 

• To meet capital expenditure on machinery and equipment.
• To meet general corporate purposes. 
• To meet the repayment of certain borrowings availed by the company.
• To meet the working capital requirements of the company. 

Accretion Pharmaceuticals IPO Registrar 

Accretion Pharmaceuticals IPO is open today, on 14th May 2025, to raise ₹29.75 crore.  Kfin Technologies Limited is the registrar of Accretion Pharmaceuticals IPO, awaiting to manage the IPO allotment procedure and refund initiation. For any queries regarding Accretion Pharmaceuticals IPO allotment and refund, you can contact Kfin Techologies Limited at reachus@kfintech.com or 04067162222, 04079611000.

Accretion Pharmaceuticals IPO Review

The Accretion Pharmaceuticals IPO has gained neutral ratings from industry experts, brokers, and institutional investors. During FY23- 24, Accretion Pharmaceuticals Limited’s revenue rose 14.93% from ₹29.53 crores in March 2023 to ₹33.94 crores in March 2024. Moreover, the company’s PAT increased by 3,780.00% from ₹0.10 crores to ₹3.88 crores.  However, industry experts suggest applying for this IPO with a long-term perspective. However, industry experts suggest that investors may park funds in this IPO for the long term.

Most analysts recommend avoiding this IPO to safeguard your investment portfolio in the stock market. However, we’re waiting for further ratings to have a better idea and will keep posting them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for the Accretion Pharmaceuticals IPO or not.

Accretion Pharmaceuticals IPO Technical Analysis

The PE ratio of Accretion Pharmaceuticals Limited shares is 21.29, and its Earnings Per Share (EPS) stands at 4.74. The Accretion Pharmaceuticals IPO can potentially deliver gains on its tentative listing date, 21st May 2025. 

For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!

FAQs on Accretion Pharmaceuticals IPO

What is Accretion Pharmaceuticals IPO GMP?

Ans. Currently, on 14th May 2025, Accretion Pharmaceuticals IPO GMP (Grey Market Premium) stands at ₹8 (7.92 % up). This indicates that the estimated listing price could be ₹109 per share.

What is the issue price of Accretion Pharmaceuticals IPO?

Ans. The Accretion Pharmaceuticals IPO price band has been set between ₹96 and ₹100 per share. Retail investors can apply for a minimum and maximum of 1 lot consisting of 1,200 shares worth ₹1,21,200. Moreover, NIIs are required to bid for a minimum of 2 lots (2,400 shares) worth ₹2,42,400.

Who is the registrar of Accretion Pharmaceuticals IPO?

Ans. Kfin Technologies Limited is the registrar of Accretion Pharmaceuticals IPO, awaiting to manage the IPO allotment procedure and refund initiation. For any queries regarding Accretion Pharmaceuticals IPO allotment and refund, you can contact Kfin Techologies Limited at reachus@kfintech.com or 04067162222, 04079611000.

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Accretion Pharmaceuticals IPO, download the Accretion Pharmaceuticals IPO RHP and Accretion Pharmaceuticals IPO DRHP. Conduct your own research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.

Recent Articles

Stocks to Watch Today: 14th May 2025 | SBI Life, HDFC Life, GAIL, EPL, Taneja, & More!

Accretion Pharmaceuticals IPO GMP & Review: Apply or Avoid?

RVNL Share surges 8% on Order Win Despite Weak Technics: Check Key Highlights Here

Integrity Infrabuild Developers IPO GMP: Day 1 IPO Live Updates

Sensex Trades 800 Points Down; Nifty50 Plunged 0.75%: Escalation of Western Border Tensions

Stocks to Watch Today: 13th May 2025 | SRF, KIMS, Raymond, HFCL, Cochin Shipyard, & More!

Trent Ltd. Share Surges 4.5% Despite Dull Q4 Performance